Foundational Models for Pathology and Endoscopy Images: Application for Gastric Inflammation.

endoscopy foundation models gastric cancer pathology

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 26 06 2024
revised: 16 08 2024
accepted: 23 08 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

The integration of artificial intelligence (AI) in medical diagnostics represents a significant advancement in managing upper gastrointestinal (GI) cancer, which is a major cause of global cancer mortality. Specifically for gastric cancer (GC), chronic inflammation causes changes in the mucosa such as atrophy, intestinal metaplasia (IM), dysplasia, and ultimately cancer. Early detection through endoscopic regular surveillance is essential for better outcomes. Foundation models (FMs), which are machine or deep learning models trained on diverse data and applicable to broad use cases, offer a promising solution to enhance the accuracy of endoscopy and its subsequent pathology image analysis. This review explores the recent advancements, applications, and challenges associated with FMs in endoscopy and pathology imaging. We started by elucidating the core principles and architectures underlying these models, including their training methodologies and the pivotal role of large-scale data in developing their predictive capabilities. Moreover, this work discusses emerging trends and future research directions, emphasizing the integration of multimodal data, the development of more robust and equitable models, and the potential for real-time diagnostic support. This review aims to provide a roadmap for researchers and practitioners in navigating the complexities of incorporating FMs into clinical practice for the prevention/management of GC cases, thereby improving patient outcomes.

Identifiants

pubmed: 39272697
pii: diagnostics14171912
doi: 10.3390/diagnostics14171912
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : The European Union
ID : 101095359
Organisme : UK Research and Innovation
ID : 10058099

Auteurs

Hamideh Kerdegari (H)

Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.

Kyle Higgins (K)

Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
Department of Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Dennis Veselkov (D)

Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.

Ivan Laponogov (I)

Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.

Inese Polaka (I)

Faculty of Medicine, Institute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.

Miguel Coimbra (M)

Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência, 3200-465 Porto, Portugal.
Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal.

Junior Andrea Pescino (JA)

StratejAI, Avenue Louise 209, 1050 Brussels, Belgium.

Mārcis Leja (M)

Faculty of Medicine, Institute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.

Mário Dinis-Ribeiro (M)

IRISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.

Tania Fleitas Kanonnikoff (T)

Instituto Investigación Sanitaria INCLIVA, Medical Oncology Department, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.

Kirill Veselkov (K)

Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
Department of Environmental Health Sciences, Yale University, New Haven, CT 06520, USA.

Classifications MeSH